(49 days)
The EUROCHAIR wheelchair family is designed mainly for adults with physical impairments that require the use of a device to assist them with their mobility needs.
Not Found
The provided text is a 510(k) premarket notification letter from the FDA for a mechanical wheelchair called "Eurochair." This document does not contain information about acceptance criteria or a study proving the device meets said criteria.
The letter confirms that the FDA has reviewed the 510(k) submission and determined the device to be "substantially equivalent" to legally marketed predicate devices. This means that the device is deemed as safe and effective as a device already on the market, but it does not detail specific performance criteria or the results of a study to demonstrate that.
Therefore, I cannot provide the requested information based on the provided text. The document is primarily an administrative letter granting market clearance based on substantial equivalence.
{0}------------------------------------------------
Image /page/0/Picture/13 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three curved lines representing its wings. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
APR 2 1 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MEYRA, Inc. Official Correspondent C/o Mr. Kirk MacKenzie Snug Seat, Inc. 12801 East Independence Boulevard Mathews, North Carolina 28106
Re: K050560
Trade/Device Name: Eurochair Regulation Number: 21 CFR 890.3850 Regulation Name: Mechanical wheelchair Regulatory Class: I Product Code: IOR Dated: March 28, 2005 Received: March 28, 2005
Dear Mr. MacKenzie:
We have reviewed your Section 510(k) premarket notification of intent to market the device wo nave re rowed your and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, de nees mat have been rout do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The r ou may, atores, include of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it your downed to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA can be found in the announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean r that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must or uny I cathates as a subtements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic forth in the quant) by ovisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
Page 2 - Mr. Kirk MacKenzie
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120 . Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Stupt Clurle
Miriam C. Provost, Ph.D. Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
INDICATIONS FOR USE
K050560 510(k) Number:
EUROCHAIR Device Name:
The EUROCHAIR wheelchair family is designed mainly for Indications for Use: adults with physical impairments that require the use of a device to assist them with their mobility needs.
Prescription Use (Part 21 CFR 801 Subpart D)
x
AND/OR
Over-The-Counter Use ) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Stytle Rhodes
(Division Sign-Off)
Division of General, Restorative, and Neurological Devices
510(k) Number K050560
§ 890.3850 Mechanical wheelchair.
(a)
Identification. A mechanical wheelchair is a manually operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.(b)
Classification. Class I (general controls).